Search
V24343
go.drugbank.com/drugs/DB05201InvestigationalThe anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.
RDP58
go.drugbank.com/drugs/DB06566ExperimentalRDP58 (NH2-arg-norleucine (nle)-nle-arg-nle-nle-nle-gly-tyr-CONH2) (Sangstat Corp., Fremont, California) is a novel synthetic peptide that inhibits early signal transduction pathways for the expression of inflammatory cytokines.
ABX-PTH
go.drugbank.com/drugs/DB05883ExperimentalABX-PTH is a fully human monoclonal antibody generated by Abgenix's technology platform. This drug targets and neutralizes the action of parathyroid hormone (PTH) for the treatment of a secondary hyperparathyroidism.
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
go.drugbank.com/drugs/DB10076ApprovedHaemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is a vaccine for intramuscular injection used in the prevention of invasive disease caused by *Haemophilus … vaccine contains the *Haemophilus influenzae* type b capsular polysaccharide (polyribosyl-ribitol-phosphate, PRP), a high-molecular-weight polymer prepared from the *H. influenzae* type b strain 1482 grown in
Alnus incana subsp. rugosa pollen
go.drugbank.com/drugs/DB10453ApprovedAlnus incana subsp. rugosa pollen is mainly used in allergenic testing.
Xanthium strumarium var. canadense pollen
go.drugbank.com/drugs/DB10462ApprovedXanthium strumarium var. canadense pollen is mainly used in allergenic testing.
Populus deltoides subsp. monilifera pollen
go.drugbank.com/drugs/DB10465ApprovedPopulus deltoides subsp. monilifera pollen is mainly used in allergenic testing.
Populus balsamifera subsp. trichocarpa pollen
go.drugbank.com/drugs/DB10754ApprovedPopulus balsamifera subsp. trichocarpa pollen is mainly used in allergenic testing.
Lolium perenne subsp. multiflorum pollen
go.drugbank.com/drugs/DB10964ApprovedLolium perenne subsp. multiflorum pollen is mainly used in allergenic testing.
Ertumaxomab
go.drugbank.com/drugs/DB18923InvestigationalErtumaxomab is under investigation in clinical trial NCT00522457 (Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy).